Patents by Inventor Louis J. Lintereur

Louis J. Lintereur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944785
    Abstract: Devices, systems, and techniques for therapy delivery and healthcare management is described. In one example, a system comprises a delivery device configured to execute therapy information comprising a treatment schedule specifying one or more treatments over a time period, wherein for each of the one or more treatments, the therapy information comprises a treatment type and a treatment amount; and processing circuitry configured to: determine a modification to the therapy information based on a recommendation of a digital twin, wherein the digital twin determines an estimated glucose level expected to be within a healthy range if the delivery device executes the modification to therapy information; and in response to physician review of the modification to the therapy information, output, to a healthcare provider system for the patient, data indicating completion of a healthcare service corresponding to the physician review.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: April 2, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Louis J. Lintereur, Catherine Tan Fogel, Patrick E. Weydt, Benyamin Grosman, Mahta Sadeghzadeh
  • Patent number: 11904139
    Abstract: A processor-implemented method for closed-loop control in steady-state conditions includes determining, based on data including historical bolus information but excluding historical basal information, an amount of unmetabolized therapeutic substance in a patient; determining, based on a difference between a most recent measurement of a physiological condition of the patient and a target value for the physiological condition, a first amount or rate of a basal dosage for delivery to the patient; adjusting, based on the amount of unmetabolized therapeutic substance, the first amount or rate of the basal dosage to determine a second amount or rate of the basal dosage; and causing delivery of the second amount or rate of the basal dosage based on communicating the second amount or rate in a delivery command.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: February 20, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Benyamin Grosman, Louis J. Lintereur, Anirban Roy, Neha J. Parikh, Di Wu, Patrick E. Weydt, David Dunleavy, Ali Dianaty
  • Patent number: 11839744
    Abstract: Techniques related to automatically generating a super bolus may include determining an amount of an augmented meal bolus to be delivered to a patient for regulating the patient's glycemic response to a meal. The amount of the augmented meal bolus may exceed a sufficient amount for counteracting a glucose level increase caused by the meal. In some embodiments, the techniques may further include determining a duration of a postprandial reduction period during which basal dosage deliveries to the patient are to be reduced. In some other embodiments, the techniques may further include delivering the augmented meal bolus to the patient prior to determining whether or not to cause reduction of basal dosage deliveries. More specifically, a glucose level of the patient may be obtained after delivery of the augmented meal bolus, and the obtained glucose level may be used to determine whether to reduce basal dosage deliveries.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: December 12, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Benyamin Grosman, Louis J. Lintereur, Anirban Roy, Neha J. Parikh, Di Wu, Patrick E. Weydt, David Dunleavy, Ali Dianaty
  • Patent number: 11839743
    Abstract: Methods, computer-readable medium, and devices that provide a graphic user interface for operating a medical infusion system are described. An exemplary method includes receiving analyte level information for a user; and providing a graphic user interface on a display element that includes an analyte level chart depicting analyte values and an infusate delivery chart. An exemplary chart depicts graphics showing basal amounts of infusate delivered by the system over time, wherein each graphic is illustrated with a dimension indicating an increased, same, or decreased amount relative to an immediately preceding graphic. Further, the exemplary chart depicts indicators showing bolus amounts delivered by the medical infusion system over time, wherein at least a portion of the bolus indicators is illustrated with a dimension not to scale.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: December 12, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Mahta Sadeghzadeh, Salman Monirabbasi, Dmytro Y. Sokolovskyy, Louis J. Lintereur, Alexander S. Campbell
  • Patent number: 11826548
    Abstract: A system includes one or more processors and one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of receiving, via a user interface, confirmation input that indicates user acceptance of a blood glucose (BG) measurement generated by a BG meter device, in response to receiving the confirmation input, using the BG measurement for performing both glucose sensor calibration and bolus calculation, and causing delivery of a bolus based on outputting a delivery command in accordance with the bolus calculation.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: November 28, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Louis J. Lintereur, Alexander S. Campbell, Taly G. Engel, David Dunleavy, Benyamin Grosman, Anirban Roy
  • Patent number: 11786655
    Abstract: Gesture-informed patient management systems and related medical devices and operating methods are provided. A method of operating a medical device involves identifying a current operational context, predicting an occurrence of an event based at least in part on historical data associated with the patient and a correlation between the current operational context and the event, automatically configuring operation of the medical device to influence a physiological condition of the patient to account for the predicted occurrence of the event, and after configuring the operation of the medical device to account for the predicted occurrence of the event, automatically reconfiguring the operation of the medical device in response to detected gesture data influenced by an output of a sensing arrangement.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: October 17, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Katelijn Vleugels, Neha J. Parikh, Lavie Golenberg, Louis J. Lintereur
  • Publication number: 20230317277
    Abstract: Techniques disclosed herein relate to gesture-based control of diabetes therapy. In some embodiments, the techniques may involve identifying at least one gesture indicative of utilization of an injection device for preparation of an insulin injection based on user activity data obtained from a wearable device disposed on an arm of a user. The techniques may further involve based on the at least one identified gesture, determining whether the insulin injection meets criteria of a proper insulin injection. The techniques may further involve outputting information indicative of whether the criteria is satisfied based on the determination.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 5, 2023
    Inventors: Patrick E. Weydt, Pratik J. Agrawal, Louis J. Lintereur, Lavie Golenberg, David Dunleavy
  • Publication number: 20230302221
    Abstract: Techniques disclosed herein relate to infusion devices and related meal bolus adjustment methods. In some embodiments, the techniques may involve determining an initial bolus amount. The techniques may further involve predicting a value for a first physiological condition based at least in part on the initial bolus amount. The techniques may further involve when the predicted value for the first physiological condition violates a threshold: identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and causing delivery of the adjusted bolus amount.
    Type: Application
    Filed: June 1, 2023
    Publication date: September 28, 2023
    Inventors: Louis J. Lintereur, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Neha J. Parikh, Di Wu, Ali Dianaty
  • Publication number: 20230277768
    Abstract: Techniques disclosed herein relate to continuous analyte sensor quality measures. In some embodiments, the techniques may involve obtaining a current sensor-generated value that is indicative of a physiological characteristic of a user of a medical device, the current sensor-generated value produced in response to operation of a continuous analyte sensor device. The techniques may further involve obtaining a sensor quality metric that indicates accuracy of the current sensor-generated value. The techniques may further involve causing, in response to obtaining the sensor quality metric, configuration of a quality-specific operating mode of the medical device, the quality-specific operating mode comprising separate regulation of basal and bolus deliveries of a fluid medication based on the obtained sensor quality metric.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 7, 2023
    Inventors: Louis J. Lintereur, Alexander S. Campbell, Dmytro Y. Sokolovskyy, Neha J. Parikh, Maria Diana Miller
  • Patent number: 11744946
    Abstract: Techniques related to automatically generating a super bolus may include determining an amount of an augmented meal bolus to be delivered to a patient for regulating the patient's glycemic response to a meal. The amount of the augmented meal bolus may exceed a sufficient amount for counteracting a glucose level increase caused by the meal. In some embodiments, the techniques may further include determining a duration of a postprandial reduction period during which basal dosage deliveries to the patient are to be reduced. In some other embodiments, the techniques may further include delivering the augmented meal bolus to the patient prior to determining whether or not to cause reduction of basal dosage deliveries. More specifically, a glucose level of the patient may be obtained after delivery of the augmented meal bolus, and the obtained glucose level may be used to determine whether to reduce basal dosage deliveries.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: September 5, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Benyamin Grosman, Louis J. Lintereur, Anirban Roy, Neha J. Parikh, Di Wu, Patrick E. Weydt, David Dunleavy, Ali Dianaty
  • Publication number: 20230248910
    Abstract: Techniques disclosed herein relate to safe correction boluses. In some embodiments, the techniques involve predicting a future glucose level that would result from delivery of a correction bolus. The techniques may also involve comparing the future glucose level to a threshold level for hypoglycemia. The techniques may further involve causing delivery of the correction bolus when the future glucose level is above the threshold level for hypoglycemia.
    Type: Application
    Filed: April 20, 2023
    Publication date: August 10, 2023
    Inventors: Louis J. Lintereur, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Neha J. Parikh, Di Wu, Ali Dianaty
  • Patent number: 11712520
    Abstract: Medical devices and related systems and operating methods are provided. A method of operating an infusion device capable of delivering fluid influencing a physiological condition to a patient involves obtaining an event indication, such as a meal indication, determining an initial bolus amount based on the event indication, and determining predicted values for the physiological condition of the patient during a time window into the future based at least in part on the initial bolus amount. When the predicted values violate a threshold during the time window, the control system identifies an adjusted bolus amount that results in the predicted values for the physiological condition satisfying the threshold during the time window from within a search space defined by the initial bolus amount and operates an actuation arrangement of the infusion device to deliver the adjusted bolus amount of the fluid to the patient.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: August 1, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Louis J. Lintereur, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Neha J. Parikh, Di Wu, Ali Dianaty
  • Patent number: 11710562
    Abstract: Devices, systems, and techniques for controlling delivery of therapy for diabetes are described. In one example, a system includes a wearable device configured to generate user activity data associated with an arm of a user; and one or more processors configured to: identify at least one gesture indicative of utilization of an injection device for preparation of an insulin injection based on the user activity data; based on the at least one identified gesture, generate information indicative of at least one of an amount or type of insulin dosage in the insulin injection by the injection device; compare the generated information to a criteria of a proper insulin injection; and output information indicative of whether the criteria is satisfied based on the comparison.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: July 25, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Patrick E. Weydt, Pratik J. Agrawal, Louis J. Lintereur, Lavie Golenberg, David Dunleavy
  • Patent number: 11690955
    Abstract: Disclosed is a method of controlling operation of a medical device that regulates delivery of a fluid medication to a user. The method obtains a current sensor-generated value that is indicative of a physiological characteristic of the user, and is produced in response to operation of a continuous analyte sensor device. The method continues by: calculating a sensor quality metric that indicates reliability and trustworthiness of the current sensor-generated value; adjusting, in response to the calculated sensor quality metric, therapy actions of the medical device to configure a quality-specific operating mode of the medical device; managing generation of user alerts at the medical device in response to the calculated sensor quality metric; and regulating delivery of the fluid medication from the medical device, in accordance with the current sensor-generated value and the quality-specific operating mode of the medical device.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: July 4, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Louis J. Lintereur, Alexander S. Campbell, Dmytro Y. Sokolovskyy, Neha J. Parikh, Maria Diana Miller
  • Patent number: 11694784
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves obtaining, by a control system associated with the infusion device, an input meal indication, obtaining historical data for the patient associated with the input meal indication, determining an estimated carbohydrate amount corresponding to the input meal indication based at least in part on the historical data, determining a bolus dosage of the insulin based at least in part on the estimated carbohydrate amount, and operating an actuation arrangement of the infusion device to deliver the bolus dosage of the insulin to the patient.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: July 4, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Benyamin Grosman, Anirban Roy, Patrick E. Weydt, Neha J. Parikh, Louis J. Lintereur, Di Wu
  • Publication number: 20230201451
    Abstract: Techniques disclosed herein relate to managing transitions into fluid delivery device operating modes. In some embodiments, the techniques involve obtaining status information pertaining to operation of a fluid delivery device, the status information including fluid delivery data, exiting a closed-loop operating mode of the fluid delivery device based on the status information, and, after exiting the closed-loop operating mode, causing generation of a user notification recommending a remedial action to improve viability of a subsequent instance of the closed-loop operating mode. The closed-loop operating mode is an operating mode in which dosage commands are automatically generated based on sensor measurement data.
    Type: Application
    Filed: March 6, 2023
    Publication date: June 29, 2023
    Inventors: Salman Monirabbasi, Louis J. Lintereur, Jin Yan
  • Patent number: 11660394
    Abstract: A method of controlling an insulin infusion device involves controlling the device to operate in an automatic basal insulin delivery mode, obtaining a blood glucose measurement for the user, and initiating a correction bolus procedure when: the measurement exceeds a correction bolus threshold value; and a maximum basal insulin infusion rate is reached during the automatic basal insulin delivery mode. The correction bolus procedure calculates an initial correction bolus amount, and scales the initial amount to obtain a final correction bolus amount, such that a predicted future blood glucose level resulting from simulated delivery of the final correction bolus amount exceeds a low blood glucose threshold level. The final amount is delivered to the user during operation in the automatic basal insulin delivery mode.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: May 30, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Louis J. Lintereur, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Neha J. Parikh, Di Wu, Ali Dianaty
  • Publication number: 20230158235
    Abstract: Techniques disclosed herein relate generally to alert management based on sleeping status. In some embodiments, the techniques involve obtaining user status data indicative of a sleeping status of a user of a medical device, and controlling alert generation and output associated with the medical device in accordance with the sleeping status of the user.
    Type: Application
    Filed: January 4, 2023
    Publication date: May 25, 2023
    Inventors: Lavie Golenberg, Louis J. Lintereur, Benyamin Grosman, Di Wu, Maria Miller
  • Patent number: 11633536
    Abstract: Techniques related to advance diagnosis of operating mode viability are disclosed. The techniques may involve obtaining status information pertaining to operation of a fluid delivery device. The status information may include at least one of a group comprising recent sensor measurement data, sensor calibration data, blood glucose reference measurement data, fluid delivery data, a current battery level of the fluid delivery device, and a current amount of fluid remaining in the fluid delivery device. The techniques may further involve determining, based on the status information, viability of transitioning to a destination operating mode of the fluid delivery device. Additionally, the techniques may involve causing generation of one or more user notifications of recommended remedial actions to improve the viability of transitioning to the destination operating mode when transitioning into the destination operating mode is determined not to be viable.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: April 25, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Salman Monirabbasi, Louis J. Lintereur, Jin Yan
  • Patent number: 11636938
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method involves operating an infusion device to deliver fluid to a user in accordance with a first operating mode of a plurality of operating modes, obtaining operational information pertaining to the first operating mode, and obtaining clinical information pertaining to the user. A destination operating mode of the plurality of operating modes is determined based at least in part on the operational information and the clinical information, and the infusion device is operated to deliver the fluid in accordance with the destination operating mode in a manner that is influenced by at least a portion of the operational information pertaining to the first operating mode.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: April 25, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Salman Monirabbasi, Louis J. Lintereur, Jin Yan, Linda I. Torres